Table 2.
Equol-producers (n 43) | Equol non-producers (n 231) | |||
---|---|---|---|---|
Mean | sd | Mean | sd | |
Age (years) | 45·7 | 2·6 | 44·9 | 2·9 |
BMI (kg/m2) | 23·8 | 2·7 | 23·7 | 3·2 |
Systolic BP (mmHg) | 123·3 | 16·7 | 124·4 | 15·7 |
Hypertension (%) | 18·6 | 25·5 | ||
Total cholesterol (mmol/l) | 5·7 | 0·9 | 5·6 | 0·9 |
LDL-cholesterol (mmol/l) | 3·6 | 0·9 | 3·5 | 0·9 |
HDL-cholesterol (mmol/l) | 1·4 | 0·3 | 1·4 | 0·4 |
Glucose (mmol/l) | ||||
Median | 5·9 | 5·7 | ||
IQR | 5·6, 6·2 | 5·4, 6·1 | ||
C-reactive protein (nmol/l) | ||||
Median | 2·7 | 3·5 | ||
IQR | 1·4, 6·1 | 1·4, 6·8 | ||
Diabetes (%) | 0·0 | 6·1 | ||
Current smokers (%) | 41·9 | 48·5 | ||
Pack-years of smoking (years) | ||||
Median | 18·0 | 17·3 | ||
IQR | 2·8, 30·0 | 2·0, 28·0 | ||
Alcohol (g/d) | ||||
Median | 20·0 | 12·0 | ||
IQR | 2·9, 37·0 | 15·1, 36·0 | ||
n-3 Fatty acids (%)† | 8·26 | 2·75 | 9·33 | 2·39* |
Meat consumption ≥2-3 times/week | 22·1 | 20·9 | ||
Education (years) | ||||
Median | 16·0 | 16·0 | ||
IQR | 12·0, 16·0 | 12·0, 16·0 | ||
Medication | ||||
Hypertension (%) | 2·3 | 4·8 | ||
Lipid (%) | 4·7 | 2·6 | ||
Exercise ≥1 h/week (%) | 30·2 | 25·1 | ||
Dietary isoflavones (nm)‡ | ||||
Median | 803·7 | 449·8 | ||
IQR | 278·9, 1346·6 | 186·7, 1030·7* | ||
CCS | ||||
50th percentile | 0·0 | 0·0 | ||
75th percentile | 0·0, 1·03 | 0·0, 1·5 | ||
Prevalence of CCS ≥10 (%) | 2·3 | 10·9 |
BP, blood pressure; CCS, coronary calcium scores.
Significant at <0·0.
n-3 Fatty acids were estimated as the sum of serum levels of EPA and DHA.
Dietary isoflavones were estimated as the sum of serum levels of daidzein and genistein.